• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国内脏肥胖成年人中低肌肉量与非酒精性脂肪性肝病风险之间关联的性别差异

Gender difference in association between low muscle mass and risk of non-alcoholic fatty liver disease among Chinese adults with visceral obesity.

作者信息

Lu Yayun, Xia Qing, Wu Liangyu, Xie Zhiping

机构信息

Health Examination Center, Huadong Sanatorium, Wuxi, China.

出版信息

Front Nutr. 2023 Jan 13;10:1026054. doi: 10.3389/fnut.2023.1026054. eCollection 2023.

DOI:10.3389/fnut.2023.1026054
PMID:36713086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9880268/
Abstract

BACKGROUND AND AIMS

Although the association between low muscle mass and the risk of non-alcoholic fatty liver disease is well-known, it has not been explored in viscerally obese populations by gender. Besides, whether low muscle mass still increases the NAFLD risk in subjects with visceral obesity, independent of obesity, is still unknown. The aim of this study was to explore the gender-specific association between low muscle mass and the risk of non-alcoholic fatty liver disease (NAFLD) in subjects with visceral obesity.

METHODS

Overall, 1,114 participants aged 19-89 years were recruited in this retrospective study. Liver disease was diagnosed by hepatic ultrasound. Skeletal muscle mass was estimated by bioimpedance analysis and defined by the appendicular skeletal muscle index (ASMI). Gender-specific differences in the ASMI value were compared between NAFLD and control groups. Restricted cubic spline and multivariate logistic regression were performed to analyze the association (stratified by gender and age) between the ASMI and the risk of NAFLD, respectively.

RESULTS

Middle-aged females (40-60 years) and males (of any age) with NAFLD had a significantly lower ASMI compared with controls (-value < 0.05). An inverse linear association was found between the ASMI and risk of NAFLD (all > 0.05). Lower quartiles of the ASMI conferred independent risk of NAFLD compared to higher quartiles (all for trend < 0.001). Low muscle mass conferred a higher risk of NAFLD in middle-aged females (adjusted odds ratio = 2.43, 95% confidence interval: 1.19-4.95) and males [18-39 years: 3.76 (1.79-7.91); 40-60 years: 4.50 (2.16-9.39); and >60 years: 4.10 (1.13-14.84)]. Besides, Low muscle mass and low muscle mass with obesity increase the risk of developing NAFLD, independent of obesity.

CONCLUSION

Among those with visceral obesity, low muscle mass increased the risk of NAFLD in males of any age, and middle-aged females, this may be explained by the postmenopausal decline in estrogen.

摘要

背景与目的

尽管低肌肉量与非酒精性脂肪性肝病风险之间的关联已为人熟知,但尚未按性别在内脏型肥胖人群中进行探讨。此外,低肌肉量在独立于肥胖的情况下,是否仍会增加内脏型肥胖受试者患非酒精性脂肪性肝病的风险尚不清楚。本研究的目的是探讨内脏型肥胖受试者中低肌肉量与非酒精性脂肪性肝病(NAFLD)风险之间的性别特异性关联。

方法

在这项回顾性研究中,共招募了1114名年龄在19 - 89岁的参与者。通过肝脏超声诊断肝脏疾病。通过生物电阻抗分析估算骨骼肌量,并由四肢骨骼肌指数(ASMI)进行定义。比较非酒精性脂肪性肝病组和对照组之间ASMI值的性别特异性差异。分别进行受限立方样条分析和多因素逻辑回归分析(按性别和年龄分层),以分析ASMI与非酒精性脂肪性肝病风险之间的关联。

结果

患有非酒精性脂肪性肝病的中年女性(40 - 60岁)和男性(任何年龄)的ASMI显著低于对照组(P值<0.05)。发现ASMI与非酒精性脂肪性肝病风险之间存在负线性关联(所有P>0.05)。与较高四分位数相比,ASMI的较低四分位数赋予非酒精性脂肪性肝病独立风险(所有趋势P<0.001)。低肌肉量在中年女性(调整后的优势比=2.43,95%置信区间:1.19 - 4.95)和男性中赋予较高的非酒精性脂肪性肝病风险[18 - 39岁:3.76(1.79 - 7.91);40 - 60岁:4.50(2.16 - 9.39);>60岁:4.10(1.13 - 14.84)]。此外,低肌肉量以及伴有肥胖的低肌肉量会增加患非酒精性脂肪性肝病的风险,独立于肥胖因素。

结论

在内脏型肥胖者中,低肌肉量会增加任何年龄男性和中年女性患非酒精性脂肪性肝病的风险,这可能是由于绝经后雌激素水平下降所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea3b/9880268/f54dbddd0fd0/fnut-10-1026054-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea3b/9880268/426c2d9f2f23/fnut-10-1026054-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea3b/9880268/bb68f83dc023/fnut-10-1026054-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea3b/9880268/f54dbddd0fd0/fnut-10-1026054-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea3b/9880268/426c2d9f2f23/fnut-10-1026054-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea3b/9880268/bb68f83dc023/fnut-10-1026054-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea3b/9880268/f54dbddd0fd0/fnut-10-1026054-g0003.jpg

相似文献

1
Gender difference in association between low muscle mass and risk of non-alcoholic fatty liver disease among Chinese adults with visceral obesity.中国内脏肥胖成年人中低肌肉量与非酒精性脂肪性肝病风险之间关联的性别差异
Front Nutr. 2023 Jan 13;10:1026054. doi: 10.3389/fnut.2023.1026054. eCollection 2023.
2
The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study.中老年人群骨骼肌质量与内脏脂肪面积比值与代谢功能障碍相关脂肪性肝病亚型的关系:一项单中心回顾性研究
Front Nutr. 2023 Nov 8;10:1246157. doi: 10.3389/fnut.2023.1246157. eCollection 2023.
3
Low appendicular skeletal muscle index increases the risk of carotid artery plaque in postmenopausal women with and without hypertension/hyperglycemia: a retrospective study.下肢骨骼肌指数低会增加绝经后女性发生颈动脉斑块的风险,无论其是否合并高血压/高血糖:一项回顾性研究。
BMC Geriatr. 2023 Jun 20;23(1):379. doi: 10.1186/s12877-023-04076-w.
4
The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.2 型糖尿病女性患者非酒精性脂肪肝与骨骼肌质量至内脏脂肪面积比值的关系。
BMC Endocr Disord. 2019 Jul 17;19(1):76. doi: 10.1186/s12902-019-0404-1.
5
Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.性别影响经肝活检证实的非酒精性脂肪性肝病患者四肢骨骼肌与内脏脂肪面积比与非酒精性脂肪性肝炎之间的关联。
Br J Nutr. 2022 Jun 14;127(11):1613-1620. doi: 10.1017/S0007114521002415. Epub 2021 Jun 28.
6
Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.韩国成年人低骨骼肌量与非酒精性脂肪性肝病的关联:第五次韩国国家健康与营养检查调查
Hepatobiliary Pancreat Dis Int. 2016 Feb;15(1):39-47. doi: 10.1016/s1499-3872(15)60030-3.
7
A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity.非肥胖非酒精性脂肪性肝病与肌少型肥胖显著相关。
Clin Nutr ESPEN. 2020 Aug;38:86-93. doi: 10.1016/j.clnesp.2020.05.025. Epub 2020 Jun 20.
8
The role of skeletal muscle in development of nonalcoholic Fatty liver disease.骨骼肌在非酒精性脂肪性肝病发病机制中的作用。
Diabetes Metab J. 2013 Aug;37(4):278-85. doi: 10.4093/dmj.2013.37.4.278. Epub 2013 Aug 14.
9
Visceral fat area to appendicular muscle mass ratio as a predictor for nonalcoholic fatty liver disease independent of obesity.内脏脂肪面积与四肢骨骼肌质量比作为非酒精性脂肪肝独立于肥胖的预测指标。
Scand J Gastroenterol. 2021 Mar;56(3):312-320. doi: 10.1080/00365521.2021.1879244. Epub 2021 Feb 3.
10
Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease.肥胖、内脏脂肪蓄积和肌肉减少症之间相加交互作用对非酒精性脂肪性肝病的影响。
Sci Rep. 2023 Mar 3;13(1):3628. doi: 10.1038/s41598-023-30833-3.

引用本文的文献

1
Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中肌肉减少症的患病率及预后
World J Gastrointest Pathophysiol. 2024 Apr 22;15(1):91100. doi: 10.4291/wjgp.v15.i1.91100.

本文引用的文献

1
Gender-Specific Impact of Metabolic Obesity Phenotypes on the Risk of Hashimoto's Thyroiditis: A Retrospective Data Analysis Using a Health Check-Up Database.代谢性肥胖表型对桥本甲状腺炎风险的性别特异性影响:一项使用健康检查数据库的回顾性数据分析。
J Inflamm Res. 2022 Feb 7;15:827-837. doi: 10.2147/JIR.S353384. eCollection 2022.
2
Metabolic Syndrome and Sarcopenia.代谢综合征与肌肉减少症
Nutrients. 2021 Oct 7;13(10):3519. doi: 10.3390/nu13103519.
3
Mechanisms and disease consequences of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的机制及疾病后果
Cell. 2021 May 13;184(10):2537-2564. doi: 10.1016/j.cell.2021.04.015.
4
Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis.非酒精性脂肪性肝炎中肌肉减少症的存在及其影响
Metabolites. 2021 Apr 15;11(4):242. doi: 10.3390/metabo11040242.
5
Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease.肌肉量与非酒精性脂肪性肝病之间的关系
Biology (Basel). 2021 Feb 5;10(2):122. doi: 10.3390/biology10020122.
6
A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors.2 型糖尿病患者肌少症的研究进展:患病率及相关因素的叙事性综述
Nutrients. 2021 Jan 9;13(1):183. doi: 10.3390/nu13010183.
7
The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men.美国男性性激素浓度与非酒精性脂肪性肝病和肝酶的关系。
Liver Int. 2021 Feb;41(2):300-310. doi: 10.1111/liv.14652.
8
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities.根据身体成分和代谢异常情况分析非酒精性脂肪性肝病的死亡率
Hepatol Commun. 2020 May 19;4(8):1136-1148. doi: 10.1002/hep4.1534. eCollection 2020 Aug.
9
Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.60 岁以上人群中的非酒精性脂肪性肝病:肌少症和肥胖的影响。
Maturitas. 2019 Jun;124:48-54. doi: 10.1016/j.maturitas.2019.03.016. Epub 2019 Mar 25.
10
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.非酒精性脂肪性肝病在鹿特丹研究中的表现:肌肉质量、肌少症、脂肪质量和脂肪分布。
J Bone Miner Res. 2019 Jul;34(7):1254-1263. doi: 10.1002/jbmr.3713. Epub 2019 May 10.